Article
Fluvastatin inhibits FLT3 glycosylation in human and murine cells and prolongs survival of mice with FLT3/ITD leukemia.
Blood - 11 Oct 2012
Williams Allen B, Li Li, Nguyen Bao, Brown Patrick, Levis Mark, Small Donald
Abstract excerpt
FLT3 is frequently mutated in acute myeloid leukemia (AML), but resistance has limited the benefit of tyrosine kinase inhibitors (TKI). We demonstrate that statins can impair FLT3 glycosylation, thus leading to loss of surface expression and induction of cell death, as well as mitigation of TKI resistance. Immunofluorescence microscopy confirms a reduction in surface localization and an increase in intracellular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
